The new imaging agent offers a non-invasive method of detecting infection and monitoring antibiotic therapy.
Stanford University medical scientists have developed a novel imaging agent that could be used to identify most bacterial infections. The study is the featured basic science article in The Journal of Nuclear Medicine’s October issue.
Bacteria are good at mutating to become resistant to antibiotics. As one way to combat the problem of antimicrobial resistance, the Centers for Disease Control and Prevention (CDC) has called for the development of novel diagnostics to detect and help manage the treatment of infectious diseases.
“We really lack tools in the clinic to be able to visualize bacterial infections,” explains Sanjiv Sam Gambhir, MD, PhD, chair of the Radiology Department and director of Precision Health and Integrated Diagnostics at Stanford University in California. “What we need is something that bacteria eat that your cells, so-called mammalian cells, do not. As it turns out, there is such an agent, and that agent is maltose, which is taken up only by bacteria because they have a transporter, called a maltodextrine transporter, on their cell wall that is able to take up maltose and small derivatives of maltose.”
The traditional way of diagnosing bacterial infection involves biopsy of the infected tissue and/or blood and culture tests. Gambhir and colleagues developed a new positron emission tomography (PET) tracer, 6?-18F-fluoromaltotriose, that offers a non-invasive means of detection. The agent is a derivative of maltose and is labeled with radioactive fluorine-18 (18F). For this study, the tracer was evaluated in several clinically relevant bacterial strains in cultures and in mouse models using a micro-PET/CT scanner. Its use to help monitor antibiotic therapies was also evaluated in rats.
The results show that 6?-18F-fluoromaltotriose was taken up in both gram-positive and gram-negative bacterial strains, and it was able to detect Pseudomonas aeruginosa in a clinically relevant mouse model of wound infection.
Gambhir points out, “This is the first time this particular maltotriose, labeled with fluorine-18, has been synthesized and used in animal models. It’s able to pick up bacteria that may be present anywhere throughout your body, and it does not lead to an imaging signal from a site of infection that does not involve bacteria.”
He notes that the new agent even identified an infection in the heart of an animal. “We could pick up very small bacterial foci in a heart valve. And then when those animals were treated with an antibiotic, we could see that the signal went away in the heart. So, the properties of the tracer of sensitivity, specificity, low background signal throughout the animal are now facilitating its translation into humans.”
The results of this pre-clinical study demonstrate that 6?-18F-fluoromaltotriose is a promising new tracer for diagnosing most bacterial infections and has the potential to change the clinical management of patients suffering from infectious diseases of bacterial origin.
Looking ahead, Gambhir says, “The hope is that in the future when someone has a potential infection, this approach of injecting the patient with fluoromaltotriose and imaging them in a PET scanner will allow localization of the signal and, therefore, the bacteria. And then, as one treats them, one can verify that the treatment is actually working—so that if it’s not working, one can quickly change to a different treatment (for example, a different antibiotic). These kinds of findings are very important for patients, because they will very likely lead to entirely new ways to manage patients with bacterial infections, no matter where those infections might be hiding in the body.”
The Latest on: Bacterial infections
- Jessie James Decker details how her 2-year-old’s bug bite led to a ‘freak’ infectionon June 25, 2020 at 5:19 pm
“The majority of staph infections are mild — 90%, perhaps even more,” Dr. Alex Viehman, an infectious disease physician at The University of Pittsburgh Medical Center, told TODAY in 2018. “However, it ...
- CDC: 465 salmonella infections in 42 states linked to backyard poultryon June 25, 2020 at 12:41 pm
About one-third of the illnesses from the salmonella outbreaks have involved children younger than five-years-old.
- A population-based study on serious inpatient bacterial infections in patients with chronic lymphocytic leukemia and their impact on survival.on June 24, 2020 at 11:05 pm
Infections in chronic lymphocytic leukemia (CLL) have been thoroughly investigated in the setting of clinical trials and single center studies. However, large cohort studies on real-world data and ...
- St. Luke's invests in machine that speeds up identification of infection-causing bacteria, fungion June 23, 2020 at 5:54 pm
"We used to do this and still do this through a lot of biochemical testing that takes hours or days to figure out what the identification is," said St. Luke's infectious-disease p ...
- The role of innate immunity in the protection conferred by a bacterial infection against cancer: study of an invertebrate modelon June 22, 2020 at 12:17 pm
The protection conferred by some infections against cancer has been recently linked to the production of acquired immunity effectors such as antibodies. However, the evolution of innate immunity as a ...
- Gio Reyna out of Dortmund game with ‘bacterial infection’ | Charlotte Observeron June 17, 2020 at 11:35 am
American attacking midfielder Gio Reyna has been ruled out of Borussia Dortmund’s Bundesliga game against Mainz because of an illness.
- Gio Reyna out of Dortmund game with ‘bacterial infection’on June 17, 2020 at 11:34 am
American attacking midfielder Gio Reyna has been ruled out of Borussia Dortmund’s Bundesliga game against Mainz because of an illness. Dortmund said ...
- Unpacking the two layers of bacterial gene regulation during plant infectionon June 15, 2020 at 8:02 am
A study in Nature Plants has revealed new insights into how pathogenic bacteria regulate gene expression during plant infection, as well as the strategies employed by plants to protect themselves from ...
- Could Bacteria in a Capsule Protect us From Coronavirus and Other Respiratory Infections?on June 11, 2020 at 7:40 pm
We’re now looking at its potential to prevent respiratory infections, including COVID-19. But how does it work?
- FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumoniaon June 4, 2020 at 1:29 pm
“These efforts provide more options to fight serious bacterial infections and get new, safe and effective therapies to patients as soon as possible.” HABP and VABP are a type of pneumonia that ...
via Google News and Bing News